Uncovering Plasticity in Tumor Lipid Metabolism.
New research reveals a previously unknown plasticity in the lipid metabolism of some tumor types. Instead of relying on the canonical SCD pathway for fatty-acid desaturation, the cells exploit a different enzyme, FADS2, and upregulate this alternative route when SCD is inhibited.